Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from MicroPort Scientific ( (HK:0853) ) is now available.
MicroPort Scientific has issued a positive profit alert, stating that it expects to swing to a net profit of at least US$20 million for the year ended 31 December 2025, compared with an audited net loss of about US$268 million a year earlier. The turnaround is attributed to roughly 70% year-on-year revenue growth in its overseas “going‑abroad” business, a 2–3 percentage-point improvement in gross margin from cost optimisation despite domestic pricing pressure in China, a 10–11% reduction in operating expenses through lean management and higher efficiency, and gains from the disposal of subsidiaries, collectively signalling a significant improvement in operational performance and financial health ahead of the full 2025 results due by end-March 2026.
The most recent analyst rating on (HK:0853) stock is a Hold with a HK$11.00 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page.
More about MicroPort Scientific
MicroPort Scientific Corporation is a medical device company based in Shanghai and incorporated in the Cayman Islands, focusing on the research, development and commercialization of innovative medical products. The group is particularly active in selling products developed in China to overseas markets, where its “going‑abroad” business has been a key growth driver, reflecting its strategic emphasis on international expansion within the global medtech industry.
Average Trading Volume: 15,168,773
Technical Sentiment Signal: Hold
Current Market Cap: HK$22.61B
See more data about 0853 stock on TipRanks’ Stock Analysis page.